Aspirin May No Longer Have Effect in Primary CVD Prevention
MONDAY, Dec. 23, 2019 -- Aspirin may not be effective for primary prevention of cardiovascular disease and cancer mortality, according to research published online Nov. 21 in Family Practice.
Frank Moriarty, Ph.D., from the Royal College of Surgeons...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Aspirin | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Family Practices | Heart | Pharmaceuticals | Royal College of Surgeons